Biomarkers predictive of atrial fibrillation in patients with cryptogenic stroke. Insights from the Nordic Atrial Fibrillation and Stroke (NOR-FIB) study.
Anna Tancin LambertBarbara Ratajczak-TretelRiadh Al-AniKathrine ArntzenGrete Kristin BakkejordHanna Marie Otterholt BekkesethVigdis BjerkeliGuttorm EldøenAnne Kristine GulsvikBente HalvorsenGudrun Anette HøieHege Ihle-HansenHaakon Ihle-HansenSusanne IngebrigtsenHenriette JohansenChristine KremerSiv Bohne KrogsethChristina KruuseMartin KurzIngvild NakstadVojtech NovotnyHalvor NaessRehman QaziMehdi Kallaj RezaiDag Marius RørholtLinn Hofsøy SteffensenJesper SømarkHåkon TobroThomas Clement TruelsenLejla WassvikKaren Lehrmann AEgidiusMaiju PesonenMirko de MelisDan AtarAnne Hege Aamodtnull nullPublished in: European journal of neurology (2023)
Several clinically established biomarkers were associated with AF. NT-proBNP performed best as AF predictor and could be used for selecting patients for long-term monitoring with ICMs.
Keyphrases
- atrial fibrillation
- oral anticoagulants
- left atrial
- catheter ablation
- left atrial appendage
- direct oral anticoagulants
- end stage renal disease
- heart failure
- ejection fraction
- percutaneous coronary intervention
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- prognostic factors
- coronary artery disease
- venous thromboembolism
- acute coronary syndrome
- brain injury